Fracture prediction from self-reported falls in routine clinical practice: a registry-based cohort study.


Journal

Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA
ISSN: 1433-2965
Titre abrégé: Osteoporos Int
Pays: England
ID NLM: 9100105

Informations de publication

Date de publication:
Nov 2019
Historique:
received: 28 05 2019
accepted: 21 07 2019
pubmed: 3 8 2019
medline: 17 6 2020
entrez: 3 8 2019
Statut: ppublish

Résumé

A simple question construct regarding number of falls in the previous year, ascertained by a single question, was strongly associated with incident fractures in routine clinical practice using a population-based dual-energy X-ray absorptiometry (DXA) registry. There is conflicting evidence from research cohorts that falls independently increase fracture risk. We examined the independent effects of falls on subsequent fractures in a large clinical registry of bone mineral density (BMD) results for the Province of Manitoba, Canada that has been systematically collecting self-reported falls information since September 1, 2012. The study population consisted of 24,943 women and men aged 40 years and older (mean age 65.5 ± 10.2 years) with fracture probability assessment (FRAX), self-reported falls for the previous year (categorized as none, 1, 2, or > 3) and fracture outcomes. Adjusted hazard ratios (HR) with 95 confidence intervals (CI) for time to fracture were estimated using Cox proportional hazards models. During mean observation time of 2.7 ± 1.0 years, 863 (3.5%) sustained one or more major osteoporotic fractures (MOF), 212 (0.8%) sustained a hip fracture, and 1210 (4.9%) sustained any incident fracture. Compared with no falls in the previous year (referent), there was a gradient of increasing risk for fracture with increasing number of falls (all P < 0.001). Results showed minimal attenuation with covariate adjustment. When adjusted for baseline fracture probability (FRAX score with BMD) the HR for MOF increased from 1.49 (95% CI 1.25-1.78) for one fall to 1.74 (1.33-2.27) for two falls to 2.62 (2.06-3.34) for ≥ 3 falls. HRs were similar for any incident fracture and slightly greater for prediction of hip fracture, reaching 3.41 (95% CI 2.19-5.31) for ≥ 3 previous falls. Self-report number of falls in the previous year is strongly associated with incident fracture risk in the routine clinical practice setting, and this risk is independent of age, sex, BMD, and baseline fracture probability. Moreover, there is dose-response with multiple falls (up to a maximum of 3) conferring greater risk than a single fall.

Identifiants

pubmed: 31372711
doi: 10.1007/s00198-019-05106-3
pii: 10.1007/s00198-019-05106-3
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2195-2203

Subventions

Organisme : Medical Research Council
ID : MC_UP_A620_1015
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/P020941/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585819
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12011/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585827
Pays : United Kingdom
Organisme : Versus Arthritis
ID : 17702
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_U147585824
Pays : United Kingdom

Références

J Clin Densitom. 2005 Spring;8(1):25-30
pubmed: 15722584
CMAJ. 2011 Feb 8;183(2):E107-14
pubmed: 21173069
J Rheumatol. 2016 Jan;43(1):26-33
pubmed: 26628597
Am J Epidemiol. 2018 Oct 1;187(10):2243-2251
pubmed: 29912266
J Clin Densitom. 2003 Fall;6(3):275-82
pubmed: 14514998
BMC Public Health. 2012 May 18;12:301
pubmed: 22537071
Bone. 2009 May;44(5):734-43
pubmed: 19195497
Osteoporos Int. 2008 Oct;19(10):1431-44
pubmed: 18324342
J Clin Densitom. 2011 Jul-Sep;14(3):194-204
pubmed: 21810525
J Bone Miner Res. 2019 Aug;34(8):1428-1435
pubmed: 31069862
J Bone Miner Res. 2018 Mar;33(3):510-516
pubmed: 29220072
Osteoporos Int. 1998;8(5):468-89
pubmed: 9850356
Arch Osteoporos. 2016 Dec;11(1):25
pubmed: 27465509
Osteoporos Int. 2017 Oct;28(10):2935-2944
pubmed: 28668994
Osteoporos Int. 2011 Mar;22(3):829-37
pubmed: 21161508
BMJ. 2012 May 22;344:e3427
pubmed: 22619194
Int J Epidemiol. 2017 Feb 1;46(1):149-161
pubmed: 27477031
J Osteoporos. 2012;2012:528790
pubmed: 22934235
Osteoporos Int. 2007 Aug;18(8):1109-17
pubmed: 17370100
Lancet. 2019 Jan 26;393(10169):364-376
pubmed: 30696576
J Bone Miner Res. 2019 Jun;34(6):1095-1100
pubmed: 30690793
Osteoporos Int. 2001;12(7):519-28
pubmed: 11527048
J Bone Miner Res. 2016 Sep;31(9):1753-9
pubmed: 27061748
Osteoporos Int. 2009 Dec;20(12):2055-61
pubmed: 19436939
J Bone Miner Res. 2010 Nov;25(11):2350-8
pubmed: 20499367
Osteoporos Int. 2018 Feb;29(2):355-363
pubmed: 29067485
Osteoporos Int. 2016 Jan;27(1):267-74
pubmed: 26391036
N Engl J Med. 1995 Mar 23;332(12):767-73
pubmed: 7862179
Osteoporos Int. 2011 Mar;22(3):817-27
pubmed: 21161509
Osteoporos Int. 2011 Sep;22(9):2395-411
pubmed: 21779818

Auteurs

W D Leslie (WD)

Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada. bleslie@sbgh.mb.ca.

S N Morin (SN)

McGill University, Montreal, Canada.

L M Lix (LM)

Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada.

P Martineau (P)

Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada.
Harvard Medical School, Boston, MA, USA.

M Bryanton (M)

Department of Medicine (C5121), University of Manitoba, 409 Tache Avenue, Winnipeg, MB, R2H 2A6, Canada.

E V McCloskey (EV)

Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.

H Johansson (H)

Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.

N C Harvey (NC)

MRC Lifecourse Epidemiology Unit, University of Southampton, Southampton, UK.
NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, UK.

J A Kanis (JA)

Centre for Metabolic Bone Diseases, University of Sheffield Medical School, Sheffield, UK.
Mary McKillop Health Institute, Australian Catholic University, Melbourne, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH